CD8A and neoplasm: Using CANOPY-1 tissue samples, three correlative analyses on CD8+ T-cell subgroups were performed to understand the role of baseline T cells in response to ICI-based treatment, namely, total CD8 count in tumor samples (low vs. high), T-cell phenotype (immune desert vs. excluded vs. inflamed), and inflamed T-cell gene expression signature (low vs. high).